Keywords: Drug discovery
Anthropic has unveiled Claude Science, a new artificial intelligence platform developed specifically for researchers, life science organizations, and pharmaceutical companies, marking the company's latest move to expand its presence in the enterprise AI market. The announcement was made during......
Nvidia has unveiled a new software platform aimed at accelerating scientific research and drug development, further strengthening its position in the rapidly growing intersection of artificial intelligence and life sciences. The company introduced the BioNeMo Agent Toolkit, a solution designed to help......
OpenAI has introduced GPT-Rosalind, a reasoning model designed for life sciences research, marking the company’s first major move into scientific AI tools focused on genomics, drug discovery, and protein engineering. The release came alongside a broad update to its Codex coding agent, which gained......
A series of recent breakthroughs highlights the growing convergence between quantum computing and artificial intelligence in pharmaceutical research, with major contributions from Harvard University, IBM, and Cleveland Clinic. On April 10, researchers at Harvard University unveiled “Cascade,”......
A new generation of artificial intelligence tools is transforming biomedical research, enabling scientists to analyze genetic regulation, decode protein structures, and design drug compounds in a fraction of the time previously required. Recent studies show that machine learning systems can compress......
-
11:33
-
11:30
-
11:16
-
11:15
-
11:00
-
11:00
-
10:45
-
10:30
-
10:18
-
10:15
-
10:14
-
10:00
-
09:45
-
09:30
-
09:15
-
09:00
-
08:45
-
08:30
-
08:28
-
08:15
-
22:00
-
21:30
-
21:00
-
20:30
-
20:00
-
19:30
-
19:00
-
18:30
-
18:00
-
17:40
-
17:30
-
17:00
-
16:30
-
16:22
-
16:15
-
16:00
-
15:30
-
15:00
-
14:30
-
14:00
-
13:34
-
13:30
-
13:08
-
13:03
-
13:00
-
12:30
-
12:00
-
11:45
